59473 Clinical and demographic predictors of the need for pharmacotherapy in Neonatal Abstinence Syndrome (NAS)
ABSTRACT IMPACT: This work has the potential to help clinicians decide which infants exposed to in utero opioids, will need to be treated early or can be discharged home early based on their risk, thus reducing prolonged hospitalization OBJECTIVES/GOALS: To develop and validate a prediction model wi...
Main Authors: | Shawana Bibi, Janis Breeze, Norma Terrin, Jonathan Davis |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2021-03-01
|
Series: | Journal of Clinical and Translational Science |
Online Access: | https://www.cambridge.org/core/product/identifier/S2059866121007718/type/journal_article |
Similar Items
-
Improving the Assessment of Neonatal Abstinence Syndrome (NAS)
by: Claire A. Chin Foo, et al.
Published: (2021-08-01) -
A review of the genomics of neonatal abstinence syndrome
by: Elizabeth Yen, et al.
Published: (2023-02-01) -
Incidence of Neonatal Abstinence Syndrome (NAS) in Castilla y Leon (Spain)
by: Miriam Moreno-Ramos, et al.
Published: (2021-12-01) -
Methadone and neonatal abstinence syndrome (NAS): what we think we know, but do not
by: John J. McCarthy, et al.
Published: (2023-12-01) -
Nursing interventions and assessment tool for neonatal abstinence syndrome (NAS): a case report
by: Lorenzo Righi, et al.
Published: (2023-08-01)